 Home > Medical News > Latest Medical News > China Biopharma's first 3 quarter financial results come out! Research and development costs over $2 billion, and arotini revenue rises

China Biopharma's first 3 quarter financial results come out! Research and development costs over $2 billion, and arotini revenue rises

 Last Update: 2020-06-01
 Source: Internet
 Author: User

Tags

sales development manager

6 2 rotation

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

On November 26, China Biopharma reported its first three-quarter results in 2019, with revenue of $19.32billion, up 22.8% Year-on-YearAmong them, liver disease drugs accounted for 25.7% of the Group's revenue, reaching 4,966 million yuan, cancer drugs accounted for 21.8% of the Group's revenue, reaching 4.202 billion yuan, cardiovascular drugs accounted for 12.9% of the Group's revenue, reaching 2.495 billion yuanSales of analgesic drugs amounted to RMB1,652 million, accounting for 8.6% of the Group's revenueinvested 2,054 million yuan in research and development
China Biopharmaceuticals invested 2,054 million yuan in research and development in the first three quarters of the year (10.6% of the Group's revenue)amrotinib grew rapidly
sales of oncology drugs amounted to RMB4.202 billion, accounting for 21.8% of the Group's revenueIts blockbuster original anti-tumor drug, Arottinib, did not disclose specific sales, but based on other variety data released, it estimated that Anrotini's sales in the first three quarters exceeded 2.5 billion.

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.